Patrick Treanor
Direktor/Vorstandsmitglied bei KALVISTA PHARMACEUTICALS, INC.
Vermögen: - $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Patrick Treanor
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Medical Specialties | 21 | |
| Public Company | Pharmaceuticals: Major | 16 | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA.
14
| Private Company | Miscellaneous Commercial Services | 14 |
| Public Company | Pharmaceuticals: Major | 13 | |
Pathalys Pharma, Inc.
 Pathalys Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pathalys Pharma, Inc. is a late-stage clinical biopharmaceutical company that focuses on developing advanced therapeutics to manage end-stage kidney disease. The company is based in Raleigh, NC. The company's initial asset is Upacicalcet, a novel calcimimetic that has the potential to improve the treatment of secondary hyperparathyroidism in hemodialysis patients. Pathalys Pharma continues to identify other high priority needs and potential solutions for patients with end-stage kidney disease. The company was founded by Ashwin Ram, Mahesh Krishnan, Jay P. Shepard, Brian Taylor Slingsby. The CEO is Neal F. Fowler.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Patrick Treanor
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
| HOLOGIC, INC. | Medical Specialties | Chairman Director/Board Member Investor Relations Contact Corporate Officer/Principal Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Sales & Marketing | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Chief Executive Officer Corporate Officer/Principal | |
| AFFYMETRIX, INC. | Medical Specialties | Director/Board Member Founder | |
Cytyc Corp.
 Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Medical Specialties | Human Resources Officer Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| EXACT SCIENCES CORPORATION | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| TALISKER RESOURCES LTD. | Precious Metals | Director/Board Member Corporate Secretary | |
| CGX ENERGY INC. | Oil & Gas Production | Director of Finance/CFO Public Communications Contact | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Zacoro Metals Corp.
 Zacoro Metals Corp. Precious MetalsNon-Energy Minerals Zacoro Metals Corp. mines and explores for gold and other metals. It engages in the mining of copper, gold, and zinc. The company is located in Toronto, Canada | Precious Metals | Director of Finance/CFO Corporate Secretary | |
| SHIRE | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal | |
Synaptive Medical, Inc.
 Synaptive Medical, Inc. Medical SpecialtiesHealth Technology Synaptive Medical, Inc. develops medical equipment and applications for neurosurgery. Its products include birghtmatter plan, guide, drive, vision and imagedrive. The firm?s solutions offer state-of-the-art technologies, including advanced surgical planning, navigation and visualization. The company was founded by Cameron Piron in 2012 and is headquartered in Toronto, Canada. | Medical Specialties | Chairman Chief Operating Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Masters Business Admin | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Masters Business Admin | |
| Stanford University | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Boston University | College/University | Doctorate Degree Masters Business Admin | |
| The University of Manchester | College/University | Graduate Degree Doctorate Degree | |
Paul Capital Partners LP
 Paul Capital Partners LP Investment ManagersFinance Founded in 1991 by Philip Paul, Paul Capital Partners LP is a private equity firm located in San Francisco with additional offices in New York City, Hong Kong, London, Paris and São Paulo. | Investment Managers | Corporate Officer/Principal Private Equity Investor | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| FORRESTER METALS INC | Other Metals/Minerals | Director/Board Member Investor Relations Contact | |
| Tufts University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| University of Western Ontario | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
Trelawney Mining & Exploration, Inc.
 Trelawney Mining & Exploration, Inc. Precious MetalsNon-Energy Minerals Trelawney Mining & Exploration, Inc. mines for gold and other miscellaneous minerals. The firm's current focus is the exploration and development of the Côté Lake Gold Deposit in the Swayze Greenstone Belt, located halfway between Timmins and Sudbury. The company was founded on July 4, 1996 and is headquartered in Toronto, Canada. | Precious Metals | Director/Board Member Corporate Secretary | |
| The State University of New York | College/University | Corporate Officer/Principal Undergraduate Degree | |
| Walter Reed Army Medical Center | Corporate Officer/Principal Corporate Officer/Principal | ||
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member General Counsel | |
Vantia Ltd.
 Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member General Counsel Founder Director/Board Member | |
Tarsa Therapeutics, Inc.
 Tarsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tarsa Therapeutics, Inc. engages in the development of therapies for the treatment and prevention of osteoporosis and related bone diseases. Its product OSTORA, is an oral formulation of calcitonin, which is a recombinant peptide hormone that inhibits bone resorption. The company was founded by David Brand and James Gilligan in 2009 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
KalVista Pharmaceuticals Ltd.
 KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Founder Corporate Officer/Principal Founder | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
| Tufts University School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
XORTX Pharma Corp.
 XORTX Pharma Corp. Pharmaceuticals: MajorHealth Technology XORTX Pharma Corp. engages in the discovery, development, and commercialization of therapies for rare diseases. It develops cardio-vascular medications for the treatment of rare diseases such as autosomal dominant polycystic kidney disease, hereditary hypouricemia, cystic fibrosis as well as large market diseases such as hypertension, metabolic syndrome, diabetes, and diabetic nephropathy. The company was founded in 2012 and is headquartered in Calgary, Canada. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Aton Partners LLC
 Aton Partners LLC Investment ManagersFinance Aton Partners LLC (Aton Partners) is a private equity and venture capital firm founded in 2013 by Daniel J. Levangie. The firm is headquartered in Auburndale, Massachusetts. | Investment Managers | Private Equity Investor Founder | |
Catalys Pacific LLC
 Catalys Pacific LLC Investment ManagersFinance Catalys Pacific LLC (Catalys Pacific) is a venture capital firm founded in 2018 by BT Slingsby. The firm is headquartered in Cayman Islands. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| RENALYTIX PLC | Packaged Software | Director/Board Member Director/Board Member | |
| MINERALYS THERAPEUTICS, INC. | Biotechnology | Founder Director/Board Member | |
Kirilys Therapeutics, Inc.
 Kirilys Therapeutics, Inc. Medical/Nursing ServicesHealth Services Kirilys Therapeutics, Inc. is an American preclinical-stage biopharmaceutical company that focuses on developing multiple precision oncology assets. The company is based in California and is committed to advancing the field of oncology. The company's initial asset is KRLS-017, a novel CDK7 inhibitor that has the potential to improve the treatment of multiple cancers. Kirilys Therapeutics was founded by Takeshi Takahashi, Brian Taylor Slingsby, and Kapil Dhingra, with Brian Taylor Slingsby serving as the CEO since incorporation. | Medical/Nursing Services | Chief Operating Officer Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 32 |
| Kanada | 10 |
| Vereinigtes Königreich | 7 |
| Dänemark | 2 |
| Irland | 2 |
Sektoral
| Health Technology | 23 |
| Consumer Services | 15 |
| Non-Energy Minerals | 5 |
| Commercial Services | 4 |
| Finance | 4 |
Operativ
| Director/Board Member | 373 |
| Corporate Officer/Principal | 149 |
| Independent Dir/Board Member | 110 |
| Director of Finance/CFO | 69 |
| President | 66 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Jim Fairbairn | 45 |
| Juliet Bakker | 41 |
| Martin Edwards | 38 |
| Albert Cha | 30 |
| Jay Shepard | 30 |
| David Singer | 28 |
| Paul van Damme | 26 |
| Walter Flamenbaum | 26 |
| Brian Pereira | 23 |
| Anthony Giovinazzo | 22 |
| John Fallon | 22 |
| Gregory Brown | 22 |
| Pamela Kirby | 22 |
| Vernon R. Loucks | 22 |
| William J. Rutter | 22 |
- Börse
- Insiders
- Patrick Treanor
- Unternehmensverbindungen
